Cite
HARVARD Citation
Bick, A. et al. (2022). Increased HIV‐1 infection in PBMCs treated in vitro with menstrual cycle phase hormones or medroxyprogesterone acetate likely occurs via different mechanisms. American journal of reproductive immunology. p. n/a. [Online].